Neuroimaging endpoints in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative, clinically heterogeneous syndrome pathologically overlapping with frontotemporal dementia. To date, therapeutic trials in animal models have not been able to predict treatment response in humans, and the revised Amyotrophic Late...
Main Authors: | Menke, R, Agosta, F, Grosskreutz, J, Filippi, M, Turner, M |
---|---|
Formato: | Journal article |
Publicado: |
Springer Verlag
2016
|
Títulos similares
-
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado: (2011) -
Neuroimaging in amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado: (2012) -
Basal ganglia alterations in amyotrophic lateral sclerosis
por: Veronica Castelnovo, et al.
Publicado: (2023-04-01) -
The tough body at the epicentre of amyotrophic lateral sclerosis
por: Turner, M, et al.
Publicado: (2017) -
Structural and functional neuroimaging in amyotrophic lateral sclerosis
por: Ilya S. Bakulin, et al.
Publicado: (2017-08-01)